ADHD Reform Associate
Houston, TX · On-site
Policy & Regulatory Impact 1. Advancement, adoption, or measurable influence on policies related to controlled substance prescribing, ADHD treatment standards, and monitoring requirements 2. Active ...
HEC Paris
2 Hec Paris Jobs Hiring Near You
ADHD Reform Associate
Houston, TX · On-site
Policy & Regulatory Impact 1. Advancement, adoption, or measurable influence on policies related to controlled substance prescribing, ADHD treatment standards, and monitoring requirements 2. Active ...
Policy & Regulatory Impact 1. Advancement, adoption, or measurable influence on policies related to controlled substance prescribing, ADHD treatment standards, and monitoring requirements 2. Active ...
Policy & Regulatory Impact 1. Advancement, adoption, or measurable influence on policies related to controlled substance prescribing, ADHD treatment standards, and monitoring requirements 2. Active ...
Full-time
Posted 2 days ago
Key responsibilities
Actively participate in legislative, regulatory, or advisory processes and contribute to policy discussions or outcomes related to ADHD treatment and controlled substance prescribing.
Develop and implement initiatives to reduce misuse, diversion, and dependency risks associated with ADHD medication.
Launch and manage education campaigns to improve awareness and understanding of responsible ADHD medication use among patients, caregivers, and providers.
Job description
Policy & Regulatory Impact
1. Advancement, adoption, or measurable influence on policies related to controlled substance prescribing, ADHD treatment standards, and monitoring requirements
2. Active participation in legislative, regulatory, or advisory processes with documented contribution to policy discussions or outcomes
3. Establishment of partnerships with key policy stakeholders, agencies, or coalitions
Responsible Prescribing & Monitory
1. Increased adoption of evidence-based prescribing guidelines among targeted provider groups
2. Implementation or expansion of monitoring framework (e.g. follow-up protocols, risk assessments, prescription tracking)
3. Demonstrated reduction in indicators of inappropriate prescribing nor prescribing variability within targeted populations or partners
Misuse & Dependency Risk Reduction
1. Development and deployment of initiatives aimed at reducing misuse, diversion, and dependency risks
2. Measurable improvement in awareness and prevention strategies among providers and patients
3. Collaboration with clinical and research partners to track and address emerging risk trends
Education & Awareness
1. Launch and reach of patient, caregiver, and provider education campaigns focused on responsible ADHD medication use
2. Increase understanding of risks, benefits, and appropriate use as measured through surveys, engagement metrics, or partner feedback
3. Creation of high-quality thought leadership
Stakeholder Engagement & Influence
1. Strength and growth of relationships with clinicians, advocacy groups, policymakers, and industry leaders
2. Formation of strategic coalitions or working groups aligned with the Foundation's mission
3. Invitations to participate in panels, advisory boards, or speaking engagements as a recognized voice in the space
Data Insights & Reporting
1. Development of clear, data-driven insights on prescribing trends, policy gaps, and patient outcomes
2. Regular reporting to Foundation leadership on progress, impact, and emerging opportunities
Organization Alignment & Impact
1. Effective integration of advocacy efforts with the Foundations' grantmaking, research, and communication strategies
2. Contribution to the Foundations reputation as a credible, balanced leader in mental health and medication policy
3. Progress toward long-term systemic change in how ADHD medications are prescribed, monitored, and understood
1. Advancement, adoption, or measurable influence on policies related to controlled substance prescribing, ADHD treatment standards, and monitoring requirements
2. Active participation in legislative, regulatory, or advisory processes with documented contribution to policy discussions or outcomes
3. Establishment of partnerships with key policy stakeholders, agencies, or coalitions
Responsible Prescribing & Monitory
1. Increased adoption of evidence-based prescribing guidelines among targeted provider groups
2. Implementation or expansion of monitoring framework (e.g. follow-up protocols, risk assessments, prescription tracking)
3. Demonstrated reduction in indicators of inappropriate prescribing nor prescribing variability within targeted populations or partners
Misuse & Dependency Risk Reduction
1. Development and deployment of initiatives aimed at reducing misuse, diversion, and dependency risks
2. Measurable improvement in awareness and prevention strategies among providers and patients
3. Collaboration with clinical and research partners to track and address emerging risk trends
Education & Awareness
1. Launch and reach of patient, caregiver, and provider education campaigns focused on responsible ADHD medication use
2. Increase understanding of risks, benefits, and appropriate use as measured through surveys, engagement metrics, or partner feedback
3. Creation of high-quality thought leadership
Stakeholder Engagement & Influence
1. Strength and growth of relationships with clinicians, advocacy groups, policymakers, and industry leaders
2. Formation of strategic coalitions or working groups aligned with the Foundation's mission
3. Invitations to participate in panels, advisory boards, or speaking engagements as a recognized voice in the space
Data Insights & Reporting
1. Development of clear, data-driven insights on prescribing trends, policy gaps, and patient outcomes
2. Regular reporting to Foundation leadership on progress, impact, and emerging opportunities
Organization Alignment & Impact
1. Effective integration of advocacy efforts with the Foundations' grantmaking, research, and communication strategies
2. Contribution to the Foundations reputation as a credible, balanced leader in mental health and medication policy
3. Progress toward long-term systemic change in how ADHD medications are prescribed, monitored, and understood
About HEC Paris
Sourced by ZipRecruiter
Headquarters location
Paris, TX, US